Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2006 | |
| Sales | 10,360,740 |
| Cost of Goods | 2,411,120 |
| Gross Profit | 7,949,610 |
| Operating Expenses | 4,506,910 |
| Operating Income | 3,442,830 |
| Interest Expense | 3,120 |
| Other Income | 987,270 |
| Pre-tax Income | 4,426,980 |
| Income Tax | 1,721,030 |
| Net Income Continuous | 2,772,254 |
| Net Income | $2,677,340 |
| EPS Basic Total Ops | 1.56 |
| EPS Basic Continuous Ops | 1.56 |
| EPS Diluted Total Ops | 1.56 |
| EPS Diluted Continuous Ops | 1.56 |
| EBITDA(a) | $3,688,360 |